SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001847903-21-000028
Filing Date
2021-12-14
Accepted
2021-12-14 07:58:10
Documents
15
Period of Report
2021-12-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cnta-20211214.htm   iXBRL 8-K 39646
2 EX-99.1 pressrelease8kex991121421.htm EX-99.1 34338
7 image_0a.jpg GRAPHIC 65390
  Complete submission text file 0001847903-21-000028.txt   365106

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20211214.xsd EX-101.SCH 2745
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20211214_def.xml EX-101.DEF 16935
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20211214_lab.xml EX-101.LAB 33041
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20211214_pre.xml EX-101.PRE 17742
8 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20211214_htm.xml XML 14650
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 211489722
SIC: 2834 Pharmaceutical Preparations